NDC 50090-4257

Saxenda

Liraglutide

Saxenda is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Liraglutide.

• Product ID: 50090-4257_81cc68a4-3ccd-4584-af92-5466603c78fb
• NDC: 50090-4257
• Product Type: Human Prescription Drug
• Proprietary Name: Saxenda
• Generic Name: Liraglutide
• Dosage Form: Injection, Solution
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2014-12-31
• Marketing Category: NDA / NDA
• Application Number: NDA206321
• Labeler Name: A-S Medication Solutions
• Substance Name: LIRAGLUTIDE
• Active Ingredient Strength: 6 mg/mL
• Pharm Classes: GLP-1 Receptor Agonist [EPC],Glucagon-Like Peptide 1 [CS],Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 50090-4257-0

5 SYRINGE, PLASTIC in 1 CARTON (50090-4257-0) > 3 mL in 1 SYRINGE, PLASTIC

• Marketing Start Date: 2019-04-09
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 50090-4257-0 [50090425700]

Saxenda INJECTION, SOLUTION

• Marketing Category: NDA
• Application Number: NDA206321
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2019-04-09

Drug Details

NDC Crossover Matching brand name "Saxenda" or generic name "Liraglutide"

NDC	Brand Name	Generic Name
0169-2800	Saxenda	liraglutide
50090-4257	Saxenda	liraglutide
0169-4060	Victoza	liraglutide
50090-2853	Victoza	liraglutide
50090-4503	Victoza	liraglutide